Product Description: SUNITIX, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib malate is described chemically as Butanedioic acid, hydroxy-, (2S)-, compound with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro1,2-dihydro-2-oxo-3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1).
| Product Name | :Sunitix |
| Generic Name | :Sunitinib |
| Formulation | :Capsule |
| Available Pack Size | : 1×6’s |
| Available Strengths | :50 mg |
| Registrations | :Bangladesh, Sri lanka, Nepal |
